Shareholder alert: weiss law investigates imara inc.

New york , oct. 14, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of imara inc. ("imara" or the "company") (nasdaq: imra) in connection with the proposed merger of the company with enliven therapeutics, inc. ("enliven"). under the terms of the merger agreement, imara will issue imara common stock as merger consideration in exchange for the cancellation of shares of capital stock of enliven and enliven will become a wholly owned subsidiary of imara.
ELVN Ratings Summary
ELVN Quant Ranking